Ciprofloxacin extended release - Depomed

Drug Profile

Ciprofloxacin extended release - Depomed

Alternative Names: Ciprofloxacin controlled release - Depomed; Ciprofloxacin gastric retention; Ciprofloxacin GR; Ciprofloxacin hydrochloride prolonged-release tablets - DepoMed; Proquin XR; URITENT; UTIMINX

Latest Information Update: 12 Mar 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Depomed
  • Class Antibacterials; Cyclopropanes; Fluoroquinolones; Piperazines; Small molecules
  • Mechanism of Action Type II DNA topoisomerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Urinary tract infections

Highest Development Phases

  • Market Withdrawal Urinary tract infections

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 31 Oct 2010 Withdrawn for Urinary tract infections in USA (PO)
  • 24 Jul 2008 Registered for Urinary tract infections in Sweden (PO, Controlled release, 500mg, Once daily)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top